27 related articles for article (PubMed ID: 31634779)
1. Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis.
Hu Y; Yu C; Cheng L; Zhong C; An J; Zou M; Liu B; Gao X
Cancer Cell Int; 2024 May; 24(1):158. PubMed ID: 38711062
[TBL] [Abstract][Full Text] [Related]
2. SOX1 promotes differentiation of nasopharyngeal carcinoma cells by activating retinoid metabolic pathway.
Lei XX; Liu Y; Wang JX; Cai Q; Yan M; He HP; Liu Q; Long ZJ; Guan Z
Cell Death Dis; 2020 May; 11(5):331. PubMed ID: 32382038
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma.
Wei W; Liu M; Ning S; Wei J; Zhong J; Li J; Cai Z; Zhang L
BMC Cancer; 2020 Jan; 20(1):6. PubMed ID: 31898536
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological biotargets and the molecular mechanisms of oxyresveratrol treating colorectal cancer: Network and experimental analyses.
Li R; Song Y; Ji Z; Li L; Zhou L
Biofactors; 2020 Jan; 46(1):158-167. PubMed ID: 31647596
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 90: biological functions, diseases, and therapeutic targets.
Wei H; Zhang Y; Jia Y; Chen X; Niu T; Chatterjee A; He P; Hou G
MedComm (2020); 2024 Feb; 5(2):e470. PubMed ID: 38283176
[TBL] [Abstract][Full Text] [Related]
6. Proteomics Profiling Reveals the Molecular Signatures and Potential Therapeutic Targets of Human Nasopharyngeal Carcinoma.
Fu Y; Liang X; Yang X; Liu J; Huang H; Zhang P; Li S; Zhu D; Zhang Y; Peng F; Chen Y; Chen Z
Mol Cell Proteomics; 2023 Jun; 22(6):100567. PubMed ID: 37172717
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
8. Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma.
Ye Q; Guo J; Chen Y; Cui Z; Chen Y
Cancer Manag Res; 2021; 13():5793-5802. PubMed ID: 34321926
[TBL] [Abstract][Full Text] [Related]
9. Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development.
Wei W; Zhou J; Chen L; Liu H; Zhang F; Li J; Ning S; Li S; Wang C; Huang Y; Zou C; Zhang L
Front Mol Biosci; 2021; 8():684836. PubMed ID: 34307453
[No Abstract] [Full Text] [Related]
10. Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis.
Xu Y; Huang X; Ye W; Zhang Y; Li C; Bai P; Lin Z; Chen C
Cancer Cell Int; 2020; 20():408. PubMed ID: 32863767
[TBL] [Abstract][Full Text] [Related]
11. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
[TBL] [Abstract][Full Text] [Related]
12. Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90.
Li HM; Ma H; Sun X; Li B; Cao C; Dai Y; Zhu M; Wu CZ
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770993
[No Abstract] [Full Text] [Related]
13. Elevated HSP90 associates with expression of HIF-1α and p-AKT and is predictive of poor prognosis in nasopharyngeal carcinoma.
Feng J; Xie G; Zhan Y; Lu J; Xu L; Fan S; Wang W
Histopathology; 2019 Aug; 75(2):202-212. PubMed ID: 30882922
[TBL] [Abstract][Full Text] [Related]
14. Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases.
Rivas-Macho A; Romeo MV; Rackles E; Olabarria G; Falcon-Perez JM; Berganza-Granda J; Cortajarena AL; Goñi-de-Cerio F
Expert Rev Mol Diagn; 2023; 23(10):875-884. PubMed ID: 37577928
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor.
Liu F; Wang L; Yi S; Liu Q; Xu X; Su M
Biomed Pharmacother; 2019 Dec; 120():109533. PubMed ID: 31634779
[TBL] [Abstract][Full Text] [Related]
16. Medical findings of nasopharyngeal carcinoma patients and anti-tumor benefits of formononetin.
Ying K; Liu Y; Zhang C; Shangguan M
Eur J Pharmacol; 2019 Oct; 861():172619. PubMed ID: 31430458
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
